David A. Siegel Invitae Corp Transaction History

Two Sigma Advisers, LP

$42.5 Billion
Q1 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.42 - $0.72 $7,392 - $12,672	17,600 Added 84.21%	38,500 $24,000
Q3 2023 Nov 14, 2023	SELL	$0.6 - $1.53 $15,540 - $39,627	-25,900 Reduced 55.34%	20,900 $12,000
Q2 2023 Aug 14, 2023	SELL	$1.05 - $1.63 $8,400 - $13,040	-8,000 Reduced 14.6%	46,800 $52,000
Q1 2023 May 15, 2023	BUY	$1.2 - $2.73 $65,760 - $149,604	54,800 New	54,800 $73,000
Q3 2022 Nov 14, 2022	SELL	$1.9 - $8.63 $6.03 Million - $27.4 Million	-3,171,875 Reduced 82.34%	680,389 $1.67 Million

Q2 2022 Aug 15, 2022	BUY	$2.13 - $9.01 $6.79 Million - $28.7 Million	3,189,000 Added 480.8%	3,852,264 $9.4 Million
Q1 2022 May 16, 2022	BUY	$6.28 - $15.59 $2.71 Million - $6.72 Million	430,900 Added 185.44%	663,264 $5.29 Million
Q4 2021 Feb 14, 2022	BUY	$14.7 - $28.67 $3.42 Million - $6.66 Million	232,364 New	232,364 $3.55 Million
Q3 2021 Nov 15, 2021	SELL	$24.31 - $33.6 $3.67 Million - $5.07 Million	-150,908 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$26.09 - $40.4 $10.6 Million - $16.4 Million	-406,000 Reduced 72.9%	150,908 $5.09 Million
Q1 2021 May 17, 2021	BUY	$33.06 - $56.93 $11.2 Million - $19.3 Million	339,000 Added 155.57%	556,908 $21.3 Million
Q4 2020 Feb 16, 2021	BUY	$39.09 - $57.4 $8.52 Million - $12.5 Million	217,908 New	217,908 $9.11 Million
Q3 2019 Nov 14, 2019	SELL	$18.85 - $27.5 $5.86 Million - $8.55 Million	-310,933 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$17.37 - $26.27 $72,954 - $110,334	4,200 Added 1.37%	310,933 $7.31 Million
Q1 2019 May 15, 2019	BUY	$10.65 - $25.75 $3.05 Million - $7.37 Million	286,289 Added 1400.36%	306,733 $7.18 Million
Q4 2018 Feb 14, 2019	BUY	$9.26 - $16.38 $189,311 - $334,872	20,444 New	20,444 $226,000

Others Institutions Holding NVTA

# of Institutions

Shares Held

7.66M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account